APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Plasma Protein Therapeutics

Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

Selected research

Industry Growth & Trends

Global Plasma Protein Therapeutics Industry Growth and Trends Forecast to 2032

Report ID 174026500121 December 2025109 pages

Choose your research edition.

Industry ResearchPlasma Protein Therapeutics Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Plasma Protein Therapeutics Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Plasma Protein Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Plasma Protein Therapeutics Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Plasma Protein Therapeutics Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.

Shire (Baxalta), CSL and Grifolsare the leaders of the Plasma Protein Therapeutics industry, which take about 55% market share. China is the major region of the global market, which takes about 45% market share.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Plasma Protein Therapeutics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Plasma Protein Therapeutics market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Plasma Protein Therapeutics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Plasma Protein Therapeutics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Plasma Protein Therapeutics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Plasma Protein Therapeutics Market by Company

Shire (Baxalta)

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

RAAS

CBPO

Hualan Bio

Kamada

Plasma Protein Therapeutics Segment by Type

Coagulation Factor

Immune Globulin

Albumin

Others

Plasma Protein Therapeutics Segment by Application

Hemophilia

PID

Others

Plasma Protein Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Protein Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Plasma Protein Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Protein Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Plasma Protein Therapeutics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Plasma Protein Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Coagulation Factor Table 2. Major Company of Immune Globulin Table 3. Major Company of Albumin Table 4. Major Company of Others Table 5. Global Plasma Protein Therapeutics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Plasma Protein Therapeutics Sales by Type (2021-2026) & (K Units) Table 7. Global Plasma Protein Therapeutics Sales Market Share in Volume by Type (2021-2026) Table 8. Global Plasma Protein Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 9. Global Plasma Protein Therapeutics Sales Market Share in Value by Type (2021-2026) Table 10. Global Plasma Protein Therapeutics Price by Type (2021-2026) & (USD/Unit) Table 11. Global Plasma Protein Therapeutics Sales by Type (2027-2032) & (K Units) Table 12. Global Plasma Protein Therapeutics Sales Market Share in Volume by Type (2027-2032) Table 13. Global Plasma Protein Therapeutics Sales by Type (2027-2032) & (US$ Million) Table 14. Global Plasma Protein Therapeutics Sales Market Share in Value by Type (2027-2032) Table 15. Global Plasma Protein Therapeutics Price by Type (2027-2032) & (USD/Unit) Table 16. North America Plasma Protein Therapeutics Sales by Type (2021-2026) & (K Units) Table 17. North America Plasma Protein Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Plasma Protein Therapeutics Sales by Type (2021-2026) & (K Units) Table 19. Europe Plasma Protein Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Plasma Protein Therapeutics Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Plasma Protein Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Plasma Protein Therapeutics Sales by Type (2021-2026) & (K Units) Table 23. Latin America Plasma Protein Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Plasma Protein Therapeutics Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Plasma Protein Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 26. Plasma Protein Therapeutics Industry Trends Table 27. Plasma Protein Therapeutics Industry Drivers Table 28. Plasma Protein Therapeutics Industry Opportunities and Challenges Table 29. Plasma Protein Therapeutics Industry Restraints Table 30. Global Plasma Protein Therapeutics Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Plasma Protein Therapeutics Revenue Market Share by Company (2021-2026) Table 32. Global Plasma Protein Therapeutics Sales by Company (2021-2026) & (K Units) Table 33. Global Plasma Protein Therapeutics Sales Share by Company (2021-2026) Table 34. Global Plasma Protein Therapeutics Market Price by Company (2021-2026) & (USD/Unit) Table 35. Global Plasma Protein Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Plasma Protein Therapeutics Major Company Production Sites and Headquarters Table 37. Global Plasma Protein Therapeutics Company, Product Type & Application Table 38. Global Plasma Protein Therapeutics Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Plasma Protein Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Plasma Protein Therapeutics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Plasma Protein Therapeutics Sales by Region (2021-2026) & (K Units) Table 43. Global Plasma Protein Therapeutics Sales Market Share in Volume by Region (2021-2026) Table 44. Global Plasma Protein Therapeutics Sales by Region (2021-2026) & (US$ Million) Table 45. Global Plasma Protein Therapeutics Sales Market Share in Value by Region (2021-2026) Table 46. Global Plasma Protein Therapeutics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 47. Global Plasma Protein Therapeutics Sales by Region (2027-2032) & (K Units) Table 48. Global Plasma Protein Therapeutics Sales Market Share in Volume by Region (2027-2032) Table 49. Global Plasma Protein Therapeutics Sales by Region (2027-2032) & (US$ Million) Table 50. Global Plasma Protein Therapeutics Sales Market Share in Value by Region (2027-2032) Table 51. Global Plasma Protein Therapeutics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 52. Global Plasma Protein Therapeutics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Plasma Protein Therapeutics Sales by Application (2021-2026) & (K Units) Table 54. Global Plasma Protein Therapeutics Sales Market Share in Volume by Application (2021-2026) Table 55. Global Plasma Protein Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 56. Global Plasma Protein Therapeutics Sales Market Share in Value by Application (2021-2026) Table 57. Global Plasma Protein Therapeutics Price by Application (2021-2026) & (USD/Unit) Table 58. Global Plasma Protein Therapeutics Sales by Application (2027-2032) & (K Units) Table 59. Global Plasma Protein Therapeutics Sales Market Share in Volume by Application (2027-2032) Table 60. Global Plasma Protein Therapeutics Sales by Application (2027-2032) & (US$ Million) Table 61. Global Plasma Protein Therapeutics Sales Market Share in Value by Application (2027-2032) Table 62. Global Plasma Protein Therapeutics Price by Application (2027-2032) & (USD/Unit) Table 63. North America Plasma Protein Therapeutics Sales by Application (2021-2026) & (K Units) Table 64. North America Plasma Protein Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Plasma Protein Therapeutics Sales by Application (2021-2026) & (K Units) Table 66. Europe Plasma Protein Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Plasma Protein Therapeutics Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Plasma Protein Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Plasma Protein Therapeutics Sales by Application (2021-2026) & (K Units) Table 70. Latin America Plasma Protein Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Plasma Protein Therapeutics Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Plasma Protein Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 73. Shire (Baxalta) Company Information Table 74. Shire (Baxalta) Business Overview Table 75. Shire (Baxalta) Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Shire (Baxalta) Plasma Protein Therapeutics Product Portfolio Table 77. Shire (Baxalta) Recent Development Table 78. CSL Company Information Table 79. CSL Business Overview Table 80. CSL Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. CSL Plasma Protein Therapeutics Product Portfolio Table 82. CSL Recent Development Table 83. Grifols Company Information Table 84. Grifols Business Overview Table 85. Grifols Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Grifols Plasma Protein Therapeutics Product Portfolio Table 87. Grifols Recent Development Table 88. Octapharma Company Information Table 89. Octapharma Business Overview Table 90. Octapharma Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Octapharma Plasma Protein Therapeutics Product Portfolio Table 92. Octapharma Recent Development Table 93. Kedrion Company Information Table 94. Kedrion Business Overview Table 95. Kedrion Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Kedrion Plasma Protein Therapeutics Product Portfolio Table 97. Kedrion Recent Development Table 98. LFB Group Company Information Table 99. LFB Group Business Overview Table 100. LFB Group Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. LFB Group Plasma Protein Therapeutics Product Portfolio Table 102. LFB Group Recent Development Table 103. Biotest Company Information Table 104. Biotest Business Overview Table 105. Biotest Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. Biotest Plasma Protein Therapeutics Product Portfolio Table 107. Biotest Recent Development Table 108. BPL Company Information Table 109. BPL Business Overview Table 110. BPL Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. BPL Plasma Protein Therapeutics Product Portfolio Table 112. BPL Recent Development Table 113. RAAS Company Information Table 114. RAAS Business Overview Table 115. RAAS Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 116. RAAS Plasma Protein Therapeutics Product Portfolio Table 117. RAAS Recent Development Table 118. CBPO Company Information Table 119. CBPO Business Overview Table 120. CBPO Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 121. CBPO Plasma Protein Therapeutics Product Portfolio Table 122. CBPO Recent Development Table 123. Hualan Bio Company Information Table 124. Hualan Bio Business Overview Table 125. Hualan Bio Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 126. Hualan Bio Plasma Protein Therapeutics Product Portfolio Table 127. Hualan Bio Recent Development Table 128. Kamada Company Information Table 129. Kamada Business Overview Table 130. Kamada Plasma Protein Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 131. Kamada Plasma Protein Therapeutics Product Portfolio Table 132. Kamada Recent Development Table 133. North America Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. North America Plasma Protein Therapeutics Sales by Country (2021-2026) & (K Units) Table 135. North America Plasma Protein Therapeutics Sales Market Share by Country (2021-2026) Table 136. North America Plasma Protein Therapeutics Sales Forecast by Country (2027-2032) & (K Units) Table 137. North America Plasma Protein Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 138. North America Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Plasma Protein Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Plasma Protein Therapeutics Market Share by Country (2021-2026) Table 141. North America Plasma Protein Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Plasma Protein Therapeutics Market Share Forecast by Country (2027-2032) Table 143. Europe Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Europe Plasma Protein Therapeutics Sales by Country (2021-2026) & (K Units) Table 145. Europe Plasma Protein Therapeutics Sales Market Share by Country (2021-2026) Table 146. Europe Plasma Protein Therapeutics Sales Forecast by Country (2027-2032) & (K Units) Table 147. Europe Plasma Protein Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 148. Europe Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Plasma Protein Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Plasma Protein Therapeutics Market Share by Country (2021-2026) Table 151. Europe Plasma Protein Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Plasma Protein Therapeutics Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Plasma Protein Therapeutics Sales by Country (2021-2026) & (K Units) Table 155. Asia-Pacific Plasma Protein Therapeutics Sales Market Share by Country (2021-2026) Table 156. Asia-Pacific Plasma Protein Therapeutics Sales Forecast by Country (2027-2032) & (K Units) Table 157. Asia-Pacific Plasma Protein Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Plasma Protein Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Plasma Protein Therapeutics Market Share by Country (2021-2026) Table 161. Asia-Pacific Plasma Protein Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Plasma Protein Therapeutics Market Share Forecast by Country (2027-2032) Table 163. Latin America Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 164. Latin America Plasma Protein Therapeutics Sales by Country (2021-2026) & (K Units) Table 165. Latin America Plasma Protein Therapeutics Sales Market Share by Country (2021-2026) Table 166. Latin America Plasma Protein Therapeutics Sales Forecast by Country (2027-2032) & (K Units) Table 167. Latin America Plasma Protein Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 168. Latin America Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Plasma Protein Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Plasma Protein Therapeutics Market Share by Country (2021-2026) Table 171. Latin America Plasma Protein Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Plasma Protein Therapeutics Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Plasma Protein Therapeutics Sales by Country (2021-2026) & (K Units) Table 175. Middle East and Africa Plasma Protein Therapeutics Sales Market Share by Country (2021-2026) Table 176. Middle East and Africa Plasma Protein Therapeutics Sales Forecast by Country (2027-2032) & (K Units) Table 177. Middle East and Africa Plasma Protein Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Plasma Protein Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East and Africa Plasma Protein Therapeutics Market Share by Country (2021-2026) Table 181. Middle East and Africa Plasma Protein Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East and Africa Plasma Protein Therapeutics Market Share Forecast by Country (2027-2032) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Plasma Protein Therapeutics Distributors List Table 186. Plasma Protein Therapeutics Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Plasma Protein Therapeutics Image Figure 2. Global Plasma Protein Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Plasma Protein Therapeutics Market Size (2021-2032) & (US$ Million) Figure 4. Global Plasma Protein Therapeutics Sales (2021-2032) & (K Units) Figure 5. Coagulation Factor Image Figure 6. Global Coagulation Factor Sales YoY Growth (2021-2032) & (K Units) Figure 7. Immune Globulin Image Figure 8. Global Immune Globulin Sales YoY Growth (2021-2032) & (K Units) Figure 9. Albumin Image Figure 10. Global Albumin Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Plasma Protein Therapeutics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Plasma Protein Therapeutics Market Share by Type 2025 VS 2032 Figure 15. North America Plasma Protein Therapeutics Sales Market Share in Volume by Type in 2025 Figure 16. North America Plasma Protein Therapeutics Sales Market Share in Value by Type in 2025 Figure 17. Europe Plasma Protein Therapeutics Sales Market Share in Volume by Type in 2025 Figure 18. Europe Plasma Protein Therapeutics Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Plasma Protein Therapeutics Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Plasma Protein Therapeutics Sales Market Share in Value by Type in 2025 Figure 21. Latin America Plasma Protein Therapeutics Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Plasma Protein Therapeutics Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Plasma Protein Therapeutics Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Plasma Protein Therapeutics Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Plasma Protein Therapeutics Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hemophilia Image Figure 28. Global Hemophilia Sales YoY Growth (2021-2032) & (K Units) Figure 29. PID Image Figure 30. Global PID Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Plasma Protein Therapeutics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Plasma Protein Therapeutics Market Share by Application 2025 VS 2032 Figure 35. North America Plasma Protein Therapeutics Sales Market Share in Volume by Application in 2025 Figure 36. North America Plasma Protein Therapeutics Sales Market Share in Value by Application in 2025 Figure 37. Europe Plasma Protein Therapeutics Sales Market Share in Volume by Application in 2025 Figure 38. Europe Plasma Protein Therapeutics Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Plasma Protein Therapeutics Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Plasma Protein Therapeutics Sales Market Share in Value by Application in 2025 Figure 41. Latin America Plasma Protein Therapeutics Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Plasma Protein Therapeutics Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Plasma Protein Therapeutics Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Plasma Protein Therapeutics Sales Market Share in Value by Application in 2025 Figure 45. North America Plasma Protein Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Plasma Protein Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Plasma Protein Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Plasma Protein Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Plasma Protein Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Plasma Protein Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Plasma Protein Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Plasma Protein Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Plasma Protein Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Plasma Protein Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Plasma Protein Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Plasma Protein Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Plasma Protein Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Plasma Protein Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Plasma Protein Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Plasma Protein Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Plasma Protein Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Plasma Protein Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Plasma Protein Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Plasma Protein Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Plasma Protein Therapeutics Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Plasma Protein Therapeutics Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Coagulation Factor
  • Immune Globulin
  • Albumin
  • Others
Applications
  • Hemophilia
  • PID
  • Others
Companies covered
  • Shire (Baxalta)
  • CSL
  • Grifols
  • Octapharma
  • Kedrion
  • LFB Group
  • Biotest
  • BPL
  • RAAS
  • CBPO
  • Hualan Bio
  • Kamada

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Plasma Protein Therapeutics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Plasma Protein Therapeutics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Plasma Protein Therapeutics Market by Type
  6. 1.3.1 Coagulation Factor
  7. 1.3.2 Immune Globulin
  8. 1.3.3 Albumin
  9. 1.3.4 Others
  10. 1.4 Global Plasma Protein Therapeutics Market Size by Type
  11. 1.4.1 Global Plasma Protein Therapeutics Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Plasma Protein Therapeutics Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Plasma Protein Therapeutics Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Plasma Protein Therapeutics Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Plasma Protein Therapeutics Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Plasma Protein Therapeutics Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Plasma Protein Therapeutics Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Plasma Protein Therapeutics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Plasma Protein Therapeutics Industry Trends
  2. 2.2 Plasma Protein Therapeutics Industry Drivers
  3. 2.3 Plasma Protein Therapeutics Industry Opportunities and Challenges
  4. 2.4 Plasma Protein Therapeutics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Plasma Protein Therapeutics Revenue (2021-2026)
  2. 3.2 Global Top Players by Plasma Protein Therapeutics Sales (2021-2026)
  3. 3.3 Global Top Players by Plasma Protein Therapeutics Price (2021-2026)
  4. 3.4 Global Plasma Protein Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Plasma Protein Therapeutics Major Company Production Sites & Headquarters
  6. 3.6 Global Plasma Protein Therapeutics Company, Product Type & Application
  7. 3.7 Global Plasma Protein Therapeutics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Plasma Protein Therapeutics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Plasma Protein Therapeutics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Plasma Protein Therapeutics Tier 1, Tier 2, and Tier 3
4 Plasma Protein Therapeutics Regional Status and Outlook
  1. 4.1 Global Plasma Protein Therapeutics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Plasma Protein Therapeutics Historic Market Size by Region
  3. 4.2.1 Global Plasma Protein Therapeutics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Plasma Protein Therapeutics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Plasma Protein Therapeutics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Plasma Protein Therapeutics Forecasted Market Size by Region
  7. 4.3.1 Global Plasma Protein Therapeutics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Plasma Protein Therapeutics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Plasma Protein Therapeutics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Plasma Protein Therapeutics by Application
  1. 5.1 Plasma Protein Therapeutics Market by Application
  2. 5.1.1 Hemophilia
  3. 5.1.2 PID
  4. 5.1.3 Others
  5. 5.2 Global Plasma Protein Therapeutics Market Size by Application
  6. 5.2.1 Global Plasma Protein Therapeutics Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Plasma Protein Therapeutics Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Plasma Protein Therapeutics Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Plasma Protein Therapeutics Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Plasma Protein Therapeutics Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Plasma Protein Therapeutics Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Plasma Protein Therapeutics Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Plasma Protein Therapeutics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shire (Baxalta)
  2. 6.1.1 Shire (Baxalta) Company Information
  3. 6.1.2 Shire (Baxalta) Business Overview
  4. 6.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shire (Baxalta) Plasma Protein Therapeutics Product Portfolio
  6. 6.1.5 Shire (Baxalta) Recent Developments
  7. 6.2 CSL
  8. 6.2.1 CSL Company Information
  9. 6.2.2 CSL Business Overview
  10. 6.2.3 CSL Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CSL Plasma Protein Therapeutics Product Portfolio
  12. 6.2.5 CSL Recent Developments
  13. 6.3 Grifols
  14. 6.3.1 Grifols Company Information
  15. 6.3.2 Grifols Business Overview
  16. 6.3.3 Grifols Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Grifols Plasma Protein Therapeutics Product Portfolio
  18. 6.3.5 Grifols Recent Developments
  19. 6.4 Octapharma
  20. 6.4.1 Octapharma Company Information
  21. 6.4.2 Octapharma Business Overview
  22. 6.4.3 Octapharma Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Octapharma Plasma Protein Therapeutics Product Portfolio
  24. 6.4.5 Octapharma Recent Developments
  25. 6.5 Kedrion
  26. 6.5.1 Kedrion Company Information
  27. 6.5.2 Kedrion Business Overview
  28. 6.5.3 Kedrion Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Kedrion Plasma Protein Therapeutics Product Portfolio
  30. 6.5.5 Kedrion Recent Developments
  31. 6.6 LFB Group
  32. 6.6.1 LFB Group Company Information
  33. 6.6.2 LFB Group Business Overview
  34. 6.6.3 LFB Group Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 LFB Group Plasma Protein Therapeutics Product Portfolio
  36. 6.6.5 LFB Group Recent Developments
  37. 6.7 Biotest
  38. 6.7.1 Biotest Company Information
  39. 6.7.2 Biotest Business Overview
  40. 6.7.3 Biotest Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Biotest Plasma Protein Therapeutics Product Portfolio
  42. 6.7.5 Biotest Recent Developments
  43. 6.8 BPL
  44. 6.8.1 BPL Company Information
  45. 6.8.2 BPL Business Overview
  46. 6.8.3 BPL Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 BPL Plasma Protein Therapeutics Product Portfolio
  48. 6.8.5 BPL Recent Developments
  49. 6.9 RAAS
  50. 6.9.1 RAAS Company Information
  51. 6.9.2 RAAS Business Overview
  52. 6.9.3 RAAS Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 RAAS Plasma Protein Therapeutics Product Portfolio
  54. 6.9.5 RAAS Recent Developments
  55. 6.10 CBPO
  56. 6.10.1 CBPO Company Information
  57. 6.10.2 CBPO Business Overview
  58. 6.10.3 CBPO Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 CBPO Plasma Protein Therapeutics Product Portfolio
  60. 6.10.5 CBPO Recent Developments
  61. 6.11 Hualan Bio
  62. 6.11.1 Hualan Bio Company Information
  63. 6.11.2 Hualan Bio Business Overview
  64. 6.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hualan Bio Plasma Protein Therapeutics Product Portfolio
  66. 6.11.5 Hualan Bio Recent Developments
  67. 6.12 Kamada
  68. 6.12.1 Kamada Company Information
  69. 6.12.2 Kamada Business Overview
  70. 6.12.3 Kamada Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Kamada Plasma Protein Therapeutics Product Portfolio
  72. 6.12.5 Kamada Recent Developments
7 North America by Country
  1. 7.1 North America Plasma Protein Therapeutics Sales by Country
  2. 7.1.1 North America Plasma Protein Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Plasma Protein Therapeutics Sales by Country (2021-2026)
  4. 7.1.3 North America Plasma Protein Therapeutics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Plasma Protein Therapeutics Market Size by Country
  6. 7.2.1 North America Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Plasma Protein Therapeutics Market Size by Country (2021-2026)
  8. 7.2.3 North America Plasma Protein Therapeutics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Plasma Protein Therapeutics Sales by Country
  2. 8.1.1 Europe Plasma Protein Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Plasma Protein Therapeutics Sales by Country (2021-2026)
  4. 8.1.3 Europe Plasma Protein Therapeutics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Plasma Protein Therapeutics Market Size by Country
  6. 8.2.1 Europe Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Plasma Protein Therapeutics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Plasma Protein Therapeutics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Plasma Protein Therapeutics Sales by Country
  2. 9.1.1 Asia-Pacific Plasma Protein Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Plasma Protein Therapeutics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Plasma Protein Therapeutics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Plasma Protein Therapeutics Market Size by Country
  6. 9.2.1 Asia-Pacific Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Plasma Protein Therapeutics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Plasma Protein Therapeutics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Plasma Protein Therapeutics Sales by Country
  2. 10.1.1 South America Plasma Protein Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Plasma Protein Therapeutics Sales by Country (2021-2026)
  4. 10.1.3 South America Plasma Protein Therapeutics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Plasma Protein Therapeutics Market Size by Country
  6. 10.2.1 South America Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Plasma Protein Therapeutics Market Size by Country (2021-2026)
  8. 10.2.3 South America Plasma Protein Therapeutics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Plasma Protein Therapeutics Sales by Country
  2. 11.1.1 Middle East and Africa Plasma Protein Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Plasma Protein Therapeutics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Plasma Protein Therapeutics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Plasma Protein Therapeutics Market Size by Country
  6. 11.2.1 Middle East and Africa Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Plasma Protein Therapeutics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Plasma Protein Therapeutics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Plasma Protein Therapeutics Value Chain Analysis
  2. 12.1.1 Plasma Protein Therapeutics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Plasma Protein Therapeutics Production Mode & Process
  7. 12.2 Plasma Protein Therapeutics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Plasma Protein Therapeutics Distributors
  10. 12.2.3 Plasma Protein Therapeutics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst